CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	9 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities:
Net loss	$ (6,097,760)	$ (5,793,845)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	276,608	278,619
Fair value of vested options issued to officers, directors and employees	459,967	1,969,483
Amortization of capitalized financing costs	731,595	158,167
Amortization of debt discount attributable to convertible debentures	1,549,230	335,342
Equity based compensation	567,083	956,438
Common stock issued in settlement of interest	34,960	102,794
Change in assets and liabilities:
Decrease in accounts receivable	(114,804)	(9,766)
Decrease (increase) in prepaid expenses and deposits	43,645	(23,221)
Increase in accounts payable and accrued liabilities	348,822	497,248
Net cash used in operating activities	(2,200,654)	(1,528,741)
Cash flows from investing activities:
Cash flows from financing activities:
Net proceeds from related party advances	550,000
Net proceeds from issuance of convertible notes	1,645,500	1,337,000
Net cash provided by financing activities	2,195,500	1,337,000
Net increase in cash and cash equivalents	(5,154)	(191,741)
Cash and cash equivalents at beginning of period	17,618	213,307
Cash and cash equivalents at end of period	12,464	21,566
Supplemental Disclosures of Cash Flow Information:
Cash paid during the period for interest
Cash paid during the period for taxes
Non-cash transactions:
Fair value of warrants issued for financing costs	217,971
Common stock issued in exchange for previously incurred debt	$ 389,960	$ 1,800,000